Barclays’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History
Bought
Maintained
Sold
Other funds holding KURE
MMFA
OMC
KFA
BCV
Barclays's KURE Position: Q1 2022 in Review
Barclays sold out of KraneShares MSCI All China Health Care Index ETF (KURE) in Q1 2022, closing a stake of 1,328 shares — an estimated $38K sold.
Barclays first reported a position in KURE in Q4 2020 and held it in 5 quarters. The position peaked at $66K in Q2 2021. 22 funds tracked by Wall St. Rank hold KURE as of Q1 2022.
- Barclays reported no remaining KraneShares MSCI All China Health Care Index ETF position as of Q1 2022 after selling out during the quarter.
- Barclays sold 1,328 KraneShares MSCI All China Health Care Index ETF shares in Q1 2022, an estimated $38K.
- Barclays first reported a position in KraneShares MSCI All China Health Care Index ETF in Q4 2020 and held it in 5 quarters.
- Barclays's KraneShares MSCI All China Health Care Index ETF position peaked at $66K in Q2 2021.
- 22 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q1 2022.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.